At the virtual ADPD 2021 event, Emily Thorp discussed engagement and adherence to remote testing in middle-aged adults at risk of dementia.
In times of a pandemic, being able to deliver cognitive tests remotely becomes even more relevant and can prevent the interruption of clinical studies: but are cognitive assessments comparable in the clinic and the home? New research, published in the Journal of Medical Internet Research, demonstrates that performance on the Cambridge Neuropsychological Test Automated Battery (CANTABTM) is broadly comparable when delivered unsupervised online or in-person in the laboratory.
Industry experts working at the forefront of drug development, devices and digital health shared their lessons learned delivering virtual trials during the Covid-19 pandemic at Cambridge Cognition’s fourth annual Digital Health Event. Catch up on the key takeways from this thought-leading discussion.
The volume of discussion and questions during our recent webinar: Remote Cognitive Testing and Lessons Learned During Lockdown was great to see. Unfortunately we were unable to answer all the questions in the time we had so Dr Caroline Skirrow has put together a Q and A addressing some of the key themes raised.
The power of remote assessments is the flexibility in when and where they can be administered. However, with this increased flexibility comes a responsibility to collect data at a frequency that is meaningful but not burdensome for the patient. This article will cover how to navigate this tricky process and strike the balance.
Remote testing solutions for clinical trials and academic research are increasingly being adopted resulting in time and cost savings for clinical research studies and reduced participation burden for study patients. However, not every study is suitable for this medium. In this article we cover the scientific and operational factors for deciding whether to use remote cognitive testing in an upcoming trial.
We are pleased to announce our partnership with Dementias Platform UK (DPUK), the world’s largest study group in dementia research formed to accelerate the development of effective, and ultimately preventative, treatments for diseases such as Alzheimer’s.
Screening patients into early stage Alzheimer’s trials can be costly and time-consuming. Kenton Zavitz, PhD, Director of Clinical Affairs proposes a potential solution for improving recruitment into clinical trials.
Exciting new research shows not only that web-based cognitive assessments are suitable for older adults but, for many, computerised assessments are actually preferable to traditional pen-and-paper tasks.
New data demonstrates possibility for speech recognition and online assessments to enhance clinical trials in Alzheimer’s disease.
A comparison of in-person and web-based computerised cognitive testing with CANTAB.
Cambridge Cognition today announces the launch of a new web-based testing product for conducting academic and clinical research studies online.